Andarine

Andarine (also known as S4 or GTx 007) a second generation Selective Androgen Receptor Modulator (commonly referred to as SARM) was developed by GTx During the muscle wasting disorders and benign prostatic hypertrophy. The potential of Andarine was explored due, to its specific interaction with androgen receptors in muscles and bones which promoted muscle building effects without major effects on androgenic tissues such as the prostate Although initial animal studies showed promise, for Andarine but it did not progress to full human clinical trials resulting in the discontinuation of its further development efforts by GTxd uring the early 2000's.Today, it is commonly found in the fitness community as a research chemical rather than an approved pharmaceutical.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.